Previous Page  117 / 120 Next Page
Information
Show Menu
Previous Page 117 / 120 Next Page
Page Background

Liposomes, Exosomes, and Virosomes: From Modeling Complex

Membrane Processes to Medical Diagnostics and Drug Delivery

Poster Abstracts

112

54-POS

Board 27

PEGylated Chol-Phospholipids-Based Nanoparticles for Encapsulation of Marine Toxins

to Cancer Therapy

Marisa P. Sarria

1

, Ivo Lopes

2

, Adelaide Miranda

1

, Pieter A. A. De Beule

1

, Begoña Espiña

1

.

1

INL - International Iberian Nanotechnology Laboratory, Braga, Portugal,

2

Nanodelivery-I&D

em Bionanotecnologia Lda. - University of Minho, Braga, Portugal.

Cancer remains still among the most difficult pathologies to surmount. Tumor cells tend to

mutate and develop resistance to available drugs. The search for improved cytotoxic agents

continues to be adamant for the discovery of novel anticancer therapies. Owing to their potent

toxicity, prospecting for novel anticancer agents among marine phyto-derived toxins seems a

promising and unexplored path to follow, and even more, if nanoscale vehicles are consider for

their targeted delivery towards cancer cells and tissues, to make the most of their interesting

features, while reducing in vivo toxicity, limited effectiveness and eventual resistance. In this

context, we investigated innovative stealth (including, pH-sensitive) liposomal nanoformulations

for marine phycotoxins encapsulation in order to target deliver and control release their well-

known potent cytotoxicity. PEGylated liposomes (mean size inferior to 120 nm) composed of

Chol-phospholipids were prepared both by thin-film hydration and ethanol injection protocols,

coupled with extrusion. Size, polydispersity and surface net-charge were evaluated via dynamic

light scattering and Z-potential analysis, respectively. For the non pH-sensitive liposomes, high

shelf-stability and conservation of the physicochemical properties along time were obtained,

independently of the nanofabrication method. The encapsulation efficiency, releasing profile and

serum stability were characterized. To boost the identification of the limits within which these

nanosystems can be applied safely, preserving the bioavailability of the loading, in vitro

validation is being pursued.